Case-Finding Strategies for Drug-Resistant Tuberculosis: Protocol for a Scoping Review

• Published in: JMIR research protocols Vol. 11; no. 12; p. e40009
• Main Authors: Van Wyk, Susanna S, Nliwasa, Marriott, Seddon, James A, Hoddinott, Graeme, Viljoen, Lario, Nepolo, Emmanuel, Günther, Gunar, Ruswa, Nunurai, Lin, Hsien-Ho, Niemann, Stefan, Gandhi, Neel R, Shah, N Sarita, Claassens, Mareli
• Format: Journal Article
• Language: English
• Published: Canada JMIR Publications 15-12-2022
• Subjects: Conflict resolution; Costs; Drug resistance; Health services; HIV; Human immunodeficiency virus; Intervention; Laboratories; Protocol; Systematic review; Tuberculosis; Africa; treatment; data; tuberculosis; systematic review; drug-resistant tuberculosis; research; acceptability; drug; feasibility; case-finding strategies; literature; clinical; transmission; case finding; model; drug-resistant; public health; policy
• ISSN: 1929-0748; 1929-0748
• DOI: 10.2196/40009

Transmission of drug-resistant tuberculosis (DR-TB) is ongoing. Finding individuals with DR-TB and initiating treatment as early as possible is important to improve patient clinical outcomes and to break the chain of transmission to control the pandemic. To our knowledge systematic reviews assessing effectiveness, cost-effectiveness, acceptability, and feasibility of different case-finding strategies for DR-TB to inform research, policy, and practice have not been conducted, and it is unknown whether enough research exists to conduct such reviews. It is unknown whether case-finding strategies are similar for DR-TB and drug-susceptible TB and whether we can draw on findings from drug-susceptible reviews to inform decisions on case-finding strategies for DR-TB.
This protocol aims to describe the available literature on case-finding for DR-TB and to describe case-finding strategies.
We will screen systematic reviews, trials, qualitative studies, diagnostic test accuracy studies, and other primary research that specifically sought to improve DR-TB case detection. We will exclude studies that invited individuals seeking care for TB symptoms, those including individuals already diagnosed with TB, or laboratory-based studies. We will search the academic databases including MEDLINE, Embase, The Cochrane Library, Africa-Wide Information, CINAHL, Epistemonikos, and PROSPERO with no language or date restrictions. We will screen titles, abstracts, and full-text articles in duplicate. Data extraction and analyses will be performed using Excel (Microsoft Corp).
We will provide a narrative report with supporting figures or tables to summarize the data. A systems-based logic model, developed from a synthesis of case-finding strategies for drug-susceptible TB, will be used as a framework to describe different strategies, resulting pathways, and enhancements of pathways. The search will be conducted at the end of 2021. Title and abstract screening, full text screening, and data extraction will be undertaken from January to June 2022. Thereafter, analysis will be conducted, and results compiled.
This scoping review will chart existing literature on case-finding for DR-TB-this will help determine whether primary studies on effectiveness, cost-effectiveness, acceptability, and feasibility of different case-finding strategies for DR-TB exist and will help formulate potential questions for a systematic review. We will also describe case-finding strategies for DR-TB and how they fit into a model of case-finding pathways for drug-susceptible TB. This review has some limitations. One limitation is the diverse, inconsistent use of intervention terminology within the literature, which may result in missing relevant studies. Poor reporting of intervention strategies may also cause misunderstanding and misclassification of interventions. Lastly, case-finding strategies for DR-TB may not fit into a model developed from strategies for drug-susceptible TB. Nevertheless, such a situation will provide an opportunity to refine the model for future research. The review will guide further research to inform decisions on case-finding policies and practices for DR-TB.
DERR1-10.2196/40009.